摘要 |
<p>Disclosed are: a novel compound which has both an antagonistic activity on an angiotensin II receptor and a PPAR³-activating activity and is therefore useful as a prophylactic and/or therapeutic agent for hypertension, heart diseases, arteriosclerosis, type-2 diabetes, diabetic complications, metabolic syndrome or the like; and a pharmaceutical composition containing the compound. Specifically disclosed are: a compound represented by general formula (I) (wherein the ring A represents a pyridine ring; the ring B represents a tetrazole ring or an oxadiazol-5(4H)-one ring; X represents C-R 5 or a nitrogen atom; R 1 represents a C 1-6 alkyl group; R 2 represents a C 1-6 alkyl group or a C 3-8 cycloalkyl group; and R 3 , R 4 , R 5 independently represent a hydrogen atom, a halogen atom, a C 1-6 alkyl group, a halo-C 1-6 alkyl group, or a C 1-6 alkoxy group which may have a substituent), a salt of the compound, or a solvate of the compound or the salt; and a pharmaceutical composition containing the compound, the salt or the solvate.</p> |
申请人 |
KOWA COMPANY, LTD. |
发明人 |
MIURA, TORU;SATO, SEIICHI;YAMADA, HAJIME;TAGASHIRA,JUNYA;SEKIMOTO, RYOHEI;ISHIDA, RIE;AOKI, HITOMI;OHGIYA, TADAAKI |